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Abstract
After ovulation, non-pregnant female giant pandas experience pseudopregnancy. During pseudopregnancy, non-pregnant
females exhibit physiological and behavioral changes similar to pregnancy. Monitoring hormonal patterns that are usually
different in pregnant mammals are not effective at determining pregnancy status in many animals that undergo
pseudopregnancy, including the giant panda. Therefore, a physiological test to distinguish between pregnancy and
pseudopregnancy in pandas has eluded scientists for decades. We examined other potential markers of pregnancy and
found that activity of the acute phase protein ceruloplasmin increases in urine of giant pandas in response to pregnancy.
Results indicate that in term pregnancies, levels of active urinary ceruloplasmin were elevated the first week of pregnancy
and remain elevated until 20–24 days prior to parturition, while no increase was observed during the luteal phase in known
pseudopregnancies. Active ceruloplasmin also increased during ultrasound-confirmed lost pregnancies; however, the
pattern was different compared to term pregnancies, particularly during the late luteal phase. In four out of the five
additional reproductive cycles included in the current study where females were bred but no birth occurred, active
ceruloplasmin in urine increased during the luteal phase. Similar to the known lost pregnancies, the temporal pattern of
change in urinary ceruloplasmin during the luteal phase deviated from the term pregnancies suggesting that these cycles
may have also been lost pregnancies. Among giant pandas in captivity, it has been presumed that there is a high rate of
pregnancy loss and our results are the first to provide evidence supporting this notion.
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Introduction
With over 300 pandas in captivity around the world, substantial
progress has been made in the ex-situ (captive) conservation of this
species in recent years, but as with any small population, careful
management is required to maintain genetic diversity and to
prevent inbreeding [1]. Although significant progress has been
made in growing the captive population, giant pandas remain a
challenge to breed in captivity due to the single estrous period per
year with sexual receptivity lasting only one to three days, mate
incompatibility, lack of sexual interest, and failure to give birth
following optimal timing of insemination. Female giant pandas
spontaneously ovulate [2] and undergo a phenomenon known as
pseudopregnancy if not pregnant, wherein a female’s reproductive
hormones are similar in concentration and length during the non-
pregnant luteal phase as during pregnancy. This makes pregnancy
determination impossible by diagnostic hormonal tests typically
used in other mammals [2,3]. In many other species, pregnancy
can be diagnosed from hormonal monitoring of the luteal steroid,
progesterone, or its excreted metabolites in urine and feces.
However, progestagen patterns between pregnant and pseudo-
pregnant pandas are indistinguishable [2,3,4,5,6]. Furthermore,
these luteal phases are unpredictable in length. They consist of a
variable primary phase lasting anywhere from around 60 to 122
days, which is characterized by a slight increase in progestagens
above baseline levels [4,5]. The primary rise of progestagens is
then followed by a more consistent secondary phase which
comprises a substantial increase in progestagens above baseline
lasting 40–50 days [4,5]. In a pregnant giant panda, the embryo
remains quiescent in embryonic diapause until the secondary rise
of progestagens when implantation is suspected to occur and the
fetus begins to grow rapidly [2,3,7,8,9].
Pregnant females do not show marked changes in behaviors until
the last two weeks of gestation, but these behaviors are often
inconsistent among females and pseudopregnant females may also
exhibit similar changes in behavior prior to the end of the luteal
phase [4]. In a limited number of cases, ultrasonography has been
helpful in the detection of a fetus or gestational sac but is only
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to parturition, following the delayed implantation [7,8]. Even then,
fetal detection can be challenging and requires the skill of an expert
ultrasonographer as well as the cooperation of the animal. While
ultrasonography has provided some evidence of failed pregnancies
due to embryonic loss in giant pandas [4,8,10], if no indications of
pregnancy are observed by ultrasound and a cub is not born after
progestagens return to baseline, it is usually assumed the female was
not pregnant. However, because ultrasound can only detect a fetus
in late gestation and females are often uncooperative at this time,
many lost pregnancies could very easily go undetected. During one
termpregnancy,thermalimaging also showedpromise fordetecting
growing fetal tissue and determining litter size in giant pandas at an
earlier stage than ultrasound [11]. However, this technique still does
not differentiate pseudopregnancy from pregnancy until after the
time of implantation. For decades, researchers all over the world
have been searching for a ‘magic bullet’ that would provide a
pregnancy test for giant pandas and other exotic wildlife that
undergo pseudopregnancy. To date, all tests utilizing steroid
hormones and their metabolites, as well as other hormones such
as relaxin, have proven ineffective for distinguishing between
pregnancy and pseudopregnancy [2,3,5,12]. Thus, the lack of a
reliable pregnancy test continues to limit our ability to understand
aspects of conception, delayed implantation/embryonic diapause,
embryonic loss and pregnancy maintenance for this species.
Recently, our laboratory began to investigate alternative
potential markers of pregnancy in the giant panda. Serum levels
of some acute phase proteins typically associated with the immune
system and inflammation were found to increase during pregnancy
in mammals such as humans and dogs [13,14,15,16]. However,
daily and even weekly blood collections from endangered/exotic
species are challenging to obtain. Therefore, we examined the
possibility of whether a marker of inflammation, the acute phase
protein ceruloplasmin, could be measured in urine collected non-
invasively and also whether it could be used to distinguish between
pregnancy and pseudopregnancy in the giant panda. Using this
approach,wediscovered thattheactivityofceruloplasmin increased
in urine of pregnant giant pandas compared to non-pregnant
animalsandthat thisincreaseoccursearlyingestationallowingfora
diagnosis of pregnancy within one week after breeding. Further-
more, the ceruloplasmin early pregnancy assay (CEP assay)
indicated a very high level of pregnancy loss in captive pandas.
Results
Active urinary ceruloplasmin in known
pseudopregnancies (no breeding) and term pregnancies
No change in the levels of active urinary ceruloplasmin was
observed throughout the estrous cycle in known pseudopregnant
giant pandas that were not bred (Figure 1). However, in pregnancies
carried to term, the levels of active ceruloplasmin in urine were
elevated by 3.2- to 19.8-fold at week one of the luteal phase
compared to the levels observed at proestrus/estrus (P#0.05;
Figure 2). These levels then remained high, ranging from 2.8- to
17.5-fold above proestrus/estrus levels, until 20–24 days prior to
birth (P#0.05; Figure 2). The secondary rise in progestagens was
calculated for each luteal phase in cycles where breeding or artificial
insemination (AI) occurred to determine the relationship between
the pattern of ceruloplasmin and progestagens. In term pregnancies,
ceruloplasmin remained increased for approximately half of the
secondary rise in progestagens (Figure 3), ranging from 42–71% of
the secondary progestagen rise, and then declined late in the luteal
phase to at or below proestrus/estrus levels for the remainder of the
cycle (Figures 2, 3). Cycles obtained from SB371 (San Diego Zoo;
SDZ) were analyzed without prior knowledge of cycle outcome. The
CEP assay accurately determined the known pseudopregnancy cycle
and both term pregnancy cycles from SB371 included in this study.
Active urinary ceruloplasmin in confirmed lost
pregnancies and suspected lost pregnancies after
breeding
Indications of pregnancy after AI were observed by ultrasound in
animal SB507 (Memphis Zoological Society, MZS) in 2007 and
2010 but no birth occurred in either year. In 2007, a gestational sac
wasobserved2 weekspriortotheend ofthe lutealphase,orbaseline
progestagens. No further development was observed and the
gestational sac degraded and regressed in the following weeks. In
2010, an early-stage fetus with a heartbeat was observed in the left
uterine horn 3 weeks prior to baseline progestagens. However, no
growth or heartbeat was observed the following week. The
gestational sac then continued to degrade and regress in the weeks
thereafter. In these confirmed lost pregnancies, the levels of active
urinary ceruloplasmin were elevated during the luteal phase but the
pattern was inconsistent with levels observed for term pregnancies
(Figure 4A and B). For the luteal phase in 2007, levels of active
ceruloplasmin did not increase until week 5 and a consistent
increase above proestrus/estrus levels did not occur until week 7
(P#0.05; Figure 4A). Interestingly, during the late luteal phase the
levels of active urinary ceruloplasmin failed to remain at proestrus/
estrus baseline values as was observed in pregnancies carried to
term. After the initial decline during the late luteal phase, active
ceruloplasmin increased again above baseline at week 18 (P#0.05;
Figure 4A). Active urinary ceruloplasmin increased by 5.4-fold
above proestrus/estrus levels during the first week of the 2010 luteal
phase, similar to what was observed in term pregnancies (P#0.05).
However, marked inconsistencies compared to term pregnancies
wereobserved duringthe late lutealphase (Figure 4B). Forexample,
the decline in ceruloplasmin during the end of the cycle occurred
early in relation to the secondary rise in progestagens, with
ceruloplasmin decreasing just 6 days after the secondary rise
(Figure 4B and D). Thus, the levels of active ceruloplasmin
remained elevated for only 14% of the secondary rise in
progestagens compared to 42–71% in term pregnancies. In
addition, although the levels of active urinary ceruloplasmin
decreased to estrus/proestrus levels at week 12, they did not remain
consistently low and increased above control levels at week 16
(P#0.05), similar to the abnormal pattern observed during the late
luteal phase of SB507’s lost pregnancy in 2007 (Figure 4A).
In the other female giant pandas examined, an increase in active
urinary ceruloplasmin was observed for many cycles in which the
animals were bred, primarily by AI, but no birth occurred.
However, there were no ultrasound data to confirm these cycles as
lost pregnancies, therefore we considered these cycles as suspected
lost pregnancies based on ceruloplasmin. Similar to what was found
in confirmed lost pregnancies, the pattern was different in these
cycles compared to known term pregnancies (Figure 5A–B). While
some of the suspected lost pregnancies were characterized as having
a delayed increase in ceruloplasmin and/or a return of active
ceruloplasmin to estrus/proestrus levels early in the luteal phase, all
of the suspected lost pregnancies had deviations in the temporal
pattern of urinary ceruloplasmin during the late luteal phase
(P#0.05). These deviations included an early decrease in active
ceruloplasmin during the secondary rise in progestagens and/or
increases in active ceruloplasmin after the initial decline during the
late luteal phase, when compared to term pregnancies (Figure 5A–
D). Out of the 7 total reproductive cycles in which animals were
bred but no birth occurred, 6 cycles had elevated ceruloplasmin
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and 4 suspected lost pregnancies based on ceruloplasmin).
Active urinary ceruloplasmin in a suspected
pseudopregnancy (no conception) after breeding or lost
pregnancy that did not elicit an inflammatory response
In urine samples obtained from female SB507 (MZS) during the
2009 breeding season, no distinct increase in active ceruloplasmin
was observed after AI (Figure 6). Urinary progestagens were
monitored to ensure a normal luteal phase (data not shown) but
the levels of active ceruloplasmin in urine remained consistent
throughout the luteal phase, similar to the levels that were
observed at proestrus and estrus (Figure 6); thus, the profile was
most closely aligned to that of known pseudopregnant animals.
Therefore, this cycle was considered a suspected pseudopregnan-
cy/no conception or lost pregnancy that did not elicit an
inflammatory response based on ceruloplasmin. This was the only
cycle where a distinct increase in active urinary ceruloplasmin did
Figure 1. The levels of active ceruloplasmin in urine for female giant pandas during known pseudopregnant cycles when no
breeding occurred. One known pseudopregnancy when no breeding or AI occurred is depicted for each female giant panda housed in U.S.
institutions. Panel A: Known pseudopregnancy in 2002 for SB437 (SNZP). Panel B: Known pseudopregnancy in 2003 for SB452 (ZA). Panel C: Known
pseudopregnancy in 2005 for SB507 (MZS). Panel D: Known pseudopregnancy in 1997 for SB371 (SDZ). Urinary progestagens were monitored in each
cycle to ensure a normal luteal phase. Urine samples from every week of the reproductive cycle could not be obtained for SB452 during her known
pseudopregnancy in 2003. PEs=Proestrus; Es=Estrus; Numerical numbers=weeks of the luteal phase. Variations in the x axis exist to accommodate
variable concentrations and durations. Data are weekly means 6 SEM; n=4 reproductive cycles. *Samples from cycles obtained from SB371 were
analyzed blind, without prior knowledge of cycle outcome.
doi:10.1371/journal.pone.0021159.g001
Urinary Ceruloplasmin as a Marker of Pregnancy
PLoS ONE | www.plosone.org 3 July 2011 | Volume 6 | Issue 7 | e21159not occur during the luteal phase out of the 7 total reproductive
cycles included in this study where animals were bred naturally or
by AI but birth did not take place.
Discussion
Ex-situ conservation of the giant panda began in the 1960s. Due
to problems like the lack of breeding in adults and high infant
mortality, the giant panda’s captive propagation history has been
plagued by inconsistent reproductive success. In recent years,
considerable improvement has been made in captive reproduction
and cub survival due to the application of techniques like artificial
insemination and improvement in husbandry and cub rearing
[17]. The ex-situ population provides numerous benefits to the
conservation of this species as a whole [1]. Opportunities for the
advancement of basic science in understanding bear biology, a
source of captive broodstock for reintroductions and transloca-
tions, and an assurance colony against wild population declines are
Figure 2. The levels of active ceruloplasmin in urine for female giant pandas during representative term pregnant cycles. Panel A:
Term pregnancy in 2005 for SB437 (SNZP). Panel B: Term pregnancy in 2006 for SB452 (ZA). Panel C: Term pregnancy in 1999 for SB371 (SDZ). Panel D:
Term pregnancy in 2003 for SB371 (SDZ). Animals were artificially inseminated (SB437; SB452) or artificially inseminated (SB371, reproductive cycle
1999) and bred naturally (SB371, reproductive cycle 2003). The amount of time active ceruloplasmin levels remained elevated in urine was dependent
upon the gestation length of each term pregnancy, but levels consistently remained high through approximately half of the secondary rise in
progestagens and then decreased to at or below proestrus/estrus levels 20–24 days prior to parturition in each pregnancy examined. SB371 was
confirmed pregnant with twins by ultrasound in 2003, but only gave birth to one cub. All other term pregnant cycles characterized produced a
singleton cub. Pg=Progestagen; PEs=Proestrus; Es=Estrus; Numerical numbers=weeks of the luteal phase. Variations in the x and y axes exist to
accommodate variable concentrations and durations. Data are weekly means 6 SEM; n=5 reproductive cycles, representative cycles (n=4) are
presented herein. *Samples from SB371 were analyzed blind, without prior knowledge of cycle outcome.
doi:10.1371/journal.pone.0021159.g002
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Conservation of Nature for maintaining a captive population [1].
After decades of research on the species’ biology and ecology there
still remain many unanswered questions, including those related to
their reproductive strategy. Pseudopregnancy, delayed implanta-
tion/embryonic diapause, and the variable length of the luteal
phase in both the pregnant and non-pregnant states are just some
of the challenges that complicate research into the reproductive
physiology of the giant panda. An accurate and straightforward
pregnancy test for giant pandas has eluded scientists for decades,
but the ability to distinguish between pregnancy and pseudopreg-
nancy is indispensable for our basic understanding of this species’
reproductive biology. The results described herein present the first
physiological test to determine pregnancy status in this species
through a non-invasive urinary assay that measures the acute
phase protein ceruloplasmin.
Ceruloplasmin is part of a family of acute phase proteins that
usually plays a protective role in response to an immune-provoking
stimulus [18,19]. It is a multifunctional copper containing protein
that was first isolated in blood in 1948 [20]. One of its main roles is
Figure 3. Urinary progestagens in representative pregnancies carried to term in female giant pandas. Black circles represent urinary
progestagen concentrations; Pg=Progestagen; PEs=Proestrus; Es=Estrus; Numerical numbers=weeks of the luteal phase. Variations in the x and y
axes exist to accommodate variable concentrations and durations. *Because urinary progestagen concentrations for SB371 were analyzed using a
different antibody, caution must be taken when directly comparing progestagen data between SB371 and the other animals. However, the same
trends were observed in the relationship between active ceruloplasmin and progestagens in urine using both antibodies.
doi:10.1371/journal.pone.0021159.g003
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sequester other free radicals [18,19,21,22]. Serum levels of
ceruloplasmin have been found to increase during normal
pregnancy in some species [14,15] and it is thought that this
increase during gestation protects against oxidative stress associ-
ated with pregnancy [18,19,21]. In dogs, the increase in serum
ceruloplasmin has been coupled to the time of embryonic
endometrial implantation and placentation [13,16]. In contrast,
our modified CEP assay showed that in giant pandas active
ceruloplasmin in urine increases within one week after conception,
indicating that this species produces an inflammatory response
well before implantation of the embryo (Figure 2). Active urinary
ceruloplasmin then remains elevated through approximately half
of the secondary rise in progestagens (Figure 3), with the secondary
rise being the presumed time of implantation. However, because
the secondary rise in progestagens occurs in both pregnant and
pseudopregnant animals, the exact timing of implantation remains
unknown in giant pandas [2,3,5].
This study also suggests that the rate of pregnancy loss among
captive giant pandas is quite high. In the two confirmed lost
pregnancies and in suspected lost pregnancies based on elevated
ceruloplasmin, the pattern deviated from the profile observed in
Figure 4. The levels of active urinary ceruloplasmin and urinary progestagens in lost pregnancies for female SB507. SB507 (MZS) was
confirmed pregnant after artificial insemination in 2007 and 2010 by ultrasound at weeks 18 and 13, respectively; however, retarded growth was
observed by ultrasound in the weeks thereafter and no birth occurred in either year. The levels of active urinary ceruloplasmin in 2007 (4A) and 2010
(4B) for SB507. Panels 4C and D: The levels of urinary progestagens in 2007 (4C) and 2010 (4D) for SB507. Red diamonds represent the levels active
urinary ceruloplasmin; Black circles represent urinary progestagen concentrations; Pg=Progestagen; Pg=Progestagen; PEs=Proestrus; Es=Estrus;
Numerical numbers=weeks of the luteal phase. Variations in the x and y axes exist to accommodate variable concentrations and durations. Data are
weekly means 6 SEM; n=2 reproductive cycles.
doi:10.1371/journal.pone.0021159.g004
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luteal phase (Figures 2–5). In term pregnancies, ceruloplasmin
remained elevated until approximately half way through the
secondary rise and then decreased late in the luteal phase to at or
below control levels for the remainder of the cycle. In contrast,
while some of the lost pregnancies showed more variability in the
pattern of urinary ceruloplasmin early in the luteal phase, all of the
confirmed and suspected lost pregnancies showed abnormalities in
the pattern of ceruloplasmin during the late luteal phase,
compared to the term pregnancy profiles. All of the cycles that
had elevated ceruloplasmin without a birth showed a deviation in
the temporal pattern of change toward the end of the luteal phase
by reaching baseline close to the onset of the secondary rise in
progestagens (the presumed time of embryo implantation) and/or
did not remain low after the primary decline to at or below estrus/
proestrus levels that occurred 20–24 days before birth in the term
Figure 5. Representative patterns of active urinary ceruloplasmin and urinary progestagens in bred/no birth cycles for female giant
pandas: suspected lost pregnancies based on ceruloplasmin. The levels of active urinary ceruloplasmin in 2008 for SB437 (SNZP; Panel 5A)
and 2001 for SB371 (SDZ; Panel 5B). Both animals were artificially inseminated. Panels 5C and D: The levels of urinary progestagens for SB437 in 2008
(5C) and for SB371 in 2001 (4D). Red diamonds represent the levels active urinary ceruloplasmin; Black circles represent urinary progestagen
concentrations; Pg=Progestagen; PEs=Proestrus; Es=Estrus; Numerical numbers=weeks of the luteal phase. Variations in the x axis exist to
accommodate variable concentrations and durations. Data are weekly means 6 SEM; n=6 reproductive cycles, representative cycles (n=2) are
presented herein. *Samples from cycles obtained from SB371 were analyzed blind, without prior knowledge of cycle outcome. Because urinary
progestagen concentrations for SB371 were analyzed using a different antibody, caution must be taken when directly comparing progestagen data
between SB371 and the other animals. However, the same trends were observed in the relationship between active ceruloplasmin and progestagens
in urine using both antibodies.
doi:10.1371/journal.pone.0021159.g005
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relationship with progestagens during the pregnant luteal phase is
depicted in Figure 7. Based on the results from this initial study,
deviations in the pattern of urinary ceruloplasmin during the
secondary luteal phase rise suggest a reduced chance of a term
pregnancy. Analysis of additional term and confirmed lost
pregnancies will help to elucidate the importance of the temporal
pattern of change in relation to term pregnancies compared to lost
pregnancies in the giant panda.
Interestingly, in SB507’s (MZS) 2009 cycle, no significant
increase was observed in the levels of active ceruloplasmin in urine
during the luteal phase, indicating that this cycle may have been a
pseudopregnancy when analyzing the cycle based on ceruloplas-
min (Figure 6). However, it is also possible that this cycle was a lost
pregnancy that did not elicit an appropriate inflammatory or
immune response. In other species, there is evidence that
immunological recognition is important for the maintenance of
pregnancy and that an inappropriate maternal response to the
fetus can result in fetal death [23,24,25,26,27,28,29]. A failed
increase in, or an abnormal pattern of, active ceruloplasmin in
urine following breeding or AI may be characteristic of an
inappropriate response to pregnancy by the maternal immune
system. Moreover, an unusual ceruloplasmin profile could also be
a sign of abnormal embryonic development. No studies examining
the specific temporal pattern of change in ceruloplasmin during
pregnancy in relation to fetal loss have been carried out in other
species. However, there is some evidence that either lower or
higher levels of ceruloplasmin compared to levels observed during
normal pregnancy could be an indication of problems associated
with gestation in humans. Abnormal levels of ceruloplasmin have
been found in blood and/or in amniotic fluid during pregnancies
which resulted in such conditions as spontaneous abortions,
preeclampsia, and Klinefelter’s syndrome [30,31,32,33,34].
These data provide a foundation for understanding conception,
fetal loss, and recognition and maintenance of pregnancy in giant
pandas. More research will be needed to further verify the rate of
lost pregnancies as well as to characterize the abnormal patterns in
ceruloplasmin that we observed in known and suspected lost
pregnancy cycles. Factors influencing pregnancy loss in captive
animals will also need to be examined. If the rate of pregnancy loss
is as high as this initial study suggests, ex-situ conservation efforts
of this iconic endangered species will improve tremendously by
subsequent investigations into the origin and mechanisms of
pregnancy recognition and maintenance. Other ursids undergo
both pseudopregnancy and delayed implantation of the embryo
[35,36,37]. Thus, these studies will provide a background for
future research in other endangered carnivores and ursids, such as
the polar bear, in which common physiological factors are
unreliable at determining pregnancy and the understanding of
many components of basic reproductive biology is lacking.
Materials and Methods
Animals and sample collection
Urine from reproductive cycles of the four adult female giant
pandas held at North American institutions was used for the study.
Females SB507, SB437, SB452 and SB371 were housed at the
Memphis Zoological Society (MZS), the Smithsonian National
Zoological Park (SNZP), Zoo Atlanta (ZA) and the San Diego Zoo
Figure 6. The levels of active ceruloplasmin in urine for a bred/
no birth cycle for female SB507: suspected pseudopregnancy/
no conception or lost pregnancy that did not elicit an immune
response based on ceruloplasmin. In 2009, SB507 (MZS) was
artificially inseminated but no change in the levels of active urinary
ceruloplasmin was observed throughout the luteal phase and levels
were similar to those observed at proestrus and estrus. Pg=Progesta-
gen; PEs=Proestrus; Es=Estrus; Numerical numbers=weeks of the
luteal phase. Data are weekly means 6 SEM; n=1 reproductive cycle.
doi:10.1371/journal.pone.0021159.g006
Figure 7. Schematic summary of elevated urinary ceruloplas-
min and its relationship with progestagens during the
pregnant luteal phase in the giant panda.
doi:10.1371/journal.pone.0021159.g007
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least 85–95% bamboo, with fruit and high fiber biscuits given as
treats, and water was provided ad libitum. Urine samples were
collected fresh, in a similar manner from each institution, via
aspiration from the animal’s enclosure and then stored frozen at
220uC. Sub-samples of urine (500 ul aliquots) from SNZP, ZA
and SDZ were shipped frozen overnight to the MZS for
ceruloplasmin analysis.
Ceruloplasmin assay
Urine samples from sixteen estrous cycles (four cycles from each
female) were used in the present study. Three to seven samples per
week were analyzed for the weeks of proestrus (when available),
estrus, and weeks 1 through the week of baseline progestagen levels
or parturition of the luteal phase/pregnancy. Known pseudopreg-
nant cycles when no breeding occurred were used as controls from
each female.
Prior to being assayed for ceruloplasmin, urine samples were
centrifuged at 3500 RPM for 10 minutes and concentrated to
300 ml. Samples were then assayed for ceruloplasmin through
oxidasic activity measurement according to the optimizations of
Sunderman and Nomoto, 1970 [38] with modifications. Briefly,
the concentration of ceruloplasmin is determined by the rate of
formation of a colored product from ceruloplasmin and the
substrate, N,N-dimethyl-p-phenylenediamine (Sigma-Aldrich, St.
Louis, MO). The rate of colorometric change is proportional to
the amount of ceruloplasmin in each sample. The change in
absorbance of the photometric product was measured every 30
seconds for a 5 minute interval using a Biomate 3 UV-Vis
spectrophotometer (Thermo Scientific, Waltham, MA). The
change in absorbance was also measured in a blank control for
each run and this value was subtracted from the change in
absorbance in each urine sample. Units of ceruloplasmin were
calculated based on the difference in the change of absorbance in
each sample from the control multiplied by reaction volume per
the unit definition of change in absorbance at 550 nm (0.01),
volume of enzyme used and the conversion factor for the
published unit definition of a 7 ml reaction volume [39]. The
inter-assay coefficient of variance was 14.9%. Creatinine was also
measured in each urine sample to account for the concentration of
water [3,40], and final ceruloplasmin concentration was expressed
per mg of creatinine. Ceruloplasmin assay validations are shown in
the Materials and Methods S1, Figures S1 and S2 and Table S1.
Progestagen enzyme immunoassays
An enzyme immunoassay (EIA) using the same progestagen
antibody (CL425; C. Munro, UCDavis, CA) and conjugate
(horseradish peroxidase progesterone conjugate; C. Munro,
UCDavis, CA) was utilized to determine urinary progestagen
concentrations for animals from SNZP, ZA and MZS. Urinary
progestagen concentrations for SB371 (SDZ) were measured at
SDZ using a single antibody EIA for the progesterone metabolite,
pregnanediol–3-glucuronide (PdG; P-26; C. Munro, UCDavis,
CA). Assay details are provided in the Materials and Methods S1.
Both the group-specific CL425 progestagen antibody and the PdG
specific antibody are widely used for captive management of the
giant panda and a similar relationship was observed between
active ceruloplasmin and the secondary rise of progestagens in
urine for term pregnant cycles when concentrations of progesta-
gens were analyzed using either antibody.
Statistical analysis
Data sets for ceruloplasmin were tested for homogeneity of
variance by Hartley’s test [41,42] and values were log transformed
before statistical analysis, if heterogeneous variance was indicated.
Changes in weekly ceruloplasmin levels for each cycle were
analyzed using a one-way analysis of variance (ANOVA) using
JMP 7 Statistical Discovery (SAS, Cary, NC). Dunnett’s test was
used to determine significant differences between weekly means of
the luteal phase and that of estrus/proestrus (baseline control) level
means. Means were considered different at P#0.05. Graphed
ceruloplasmin values are presented as weekly means 6 SEM of
non-transformed values and represent 3–7 urine samples/week.
For each luteal phase, the primary and secondary rise in urinary
progestagens were determined by an iterative method as described
previously for fecal progestagens [5]. Briefly, the primary rise was
regarded as the time from the beginning of the luteal phase until
the elevation of progestagens to 2 standard deviations above the
mean for two or more days, while the secondary rise in urinary
progestagens was the duration from the end of the primary rise
until the end of the luteal phase. Termination of the luteal phase
was defined as either parturition (term pregnancies) or the return
to baseline progestagens (all other cycles).
Supporting Information
Figure S1 The effect of freeze-thaw cycles on the levels
of active ceruloplasmin in urine obtained from giant
pandas. Repeated freeze-thaw cycles could affect the levels of
active ceruloplasmin in urine. Ceruloplasmin activity was





th thaws, respectively, compared to the activity observed
at the initial measurement (set to 100%). Because banked samples
had been frozen and thawed on numerous occasions and the exact
number of freeze-thaw cycles was unknown and inconsistent
between cycles, samples were not analyzed between different
cycles. Data are the percent mean decrease in ceruloplasmin
activity from the activity found at the initial thaw for the current
study 6 SEM; n=3 samples.
(TIF)
Figure S2 The effects of boiling on the levels of active
ceruloplasmin in urine obtained from giant pandas.
Change in absorbance in each urine sample was measured prior to
boiling and then after boiling for 10 or 30 minutes. Boiling for 10
minutes produced a decrease in activity by an average of 34%,
while boiling for 30 minutes produced a decrease in activity by an
average of 65%, compared to the ceruloplasmin activity observed
with no treatment (set to 100%). Data are the percent mean
decrease in ceruloplasmin activity from the activity found at the
initial measurement 6 SEM; n=4 samples.
(TIF)
Table S1 Comparison of active ceruloplasmin values in
sample pools of giant panda urine obtained from the
change in absorbance/ml enzyme method and standard
curve method. To check the validity that the rate of colorimetric
change is proportional to the amount of ceruloplasmin in giant
panda urine, values obtained from the change in absorbance/ml
enzyme calculation method were compared to values obtained
from a standard curve method. For the change in absorbance/ml
enzyme calculation method, units of ceruloplasmin in two pools (a
high and low pool) were calculated based on the difference in the
change of absorbance in each sample from the blank control
multiplied by reaction volume per unit definition for the change in
absorbance at 550 nm (0.01), volume of enzyme used and the
published conversion factor for the unit definition of a 7 ml
reaction volume [39]. For the standard curve method, after
subtracting the change of absorbance in each sample from the
Urinary Ceruloplasmin as a Marker of Pregnancy
PLoS ONE | www.plosone.org 9 July 2011 | Volume 6 | Issue 7 | e21159blank control, units of ceruloplasmin in each pool were calculated
both manually using the linear regression (LR) equation obtained
from the standard curve; y=0.0067x20.0011 and by using Sigma
Plot software (Systat Software Inc., San Jose, CA) to calculate the
values using a 4-parameter logistic (4PL) curve fit. A. The raw
values of active ceruloplasmin for pool dilutions; values are
expressed as u/ml enzyme* (change in absorbance/ml enzyme
method) or u/ml* (standard curve method). B. Raw values of
active ceruloplasmin by dilution factor; values are expressed as u/
ml enzyme* (change in absorbance/ml enzyme method) or u/
ml*(standard curve method). *Values are not expressed on a per
mg of creatinine basis.
(DOC)
Materials and Methods S1
(DOC)
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